↓ Skip to main content

Preclinical Evidence of an Allogeneic Dual CD20xCD22 CAR to Target a Broad Spectrum of Patients with B-cell Malignancies

Overview of attention for article published in Cancer Immunology Research, May 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#7 of 1,518)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
44 news outlets
twitter
5 X users

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Preclinical Evidence of an Allogeneic Dual CD20xCD22 CAR to Target a Broad Spectrum of Patients with B-cell Malignancies
Published in
Cancer Immunology Research, May 2023
DOI 10.1158/2326-6066.cir-22-0910
Pubmed ID
Authors

Beatriz Aranda-Orgilles, Isabelle Chion-Sotinel, Jordan Skinner, Steven Grudman, Ben Mumford, Chantel Dixon, Jorge Postigo Fernandez, Piril Erler, Phillipe Duchateau, Agnes Gouble, Roman Galetto, Laurent Poirot

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 18%
Unknown 9 82%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 1 9%
Engineering 1 9%
Unknown 9 82%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 306. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 July 2023.
All research outputs
#111,034
of 25,247,084 outputs
Outputs from Cancer Immunology Research
#7
of 1,518 outputs
Outputs of similar age
#2,586
of 376,005 outputs
Outputs of similar age from Cancer Immunology Research
#5
of 32 outputs
Altmetric has tracked 25,247,084 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,518 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 376,005 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.